ATE329263T1 - Regionen variabler schwerer ketten und variabler leichter ketten von antikörpern für humanes blutplättchen-glykoprotein ib alpha - Google Patents

Regionen variabler schwerer ketten und variabler leichter ketten von antikörpern für humanes blutplättchen-glykoprotein ib alpha

Info

Publication number
ATE329263T1
ATE329263T1 AT99971513T AT99971513T ATE329263T1 AT E329263 T1 ATE329263 T1 AT E329263T1 AT 99971513 T AT99971513 T AT 99971513T AT 99971513 T AT99971513 T AT 99971513T AT E329263 T1 ATE329263 T1 AT E329263T1
Authority
AT
Austria
Prior art keywords
heavy chain
light chain
alpha
antibody
variable
Prior art date
Application number
AT99971513T
Other languages
German (de)
English (en)
Inventor
Jonathan L Miller
Original Assignee
Jonathan L Miller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonathan L Miller filed Critical Jonathan L Miller
Application granted granted Critical
Publication of ATE329263T1 publication Critical patent/ATE329263T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99971513T 1998-10-30 1999-10-29 Regionen variabler schwerer ketten und variabler leichter ketten von antikörpern für humanes blutplättchen-glykoprotein ib alpha ATE329263T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10627598P 1998-10-30 1998-10-30

Publications (1)

Publication Number Publication Date
ATE329263T1 true ATE329263T1 (de) 2006-06-15

Family

ID=22310524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971513T ATE329263T1 (de) 1998-10-30 1999-10-29 Regionen variabler schwerer ketten und variabler leichter ketten von antikörpern für humanes blutplättchen-glykoprotein ib alpha

Country Status (8)

Country Link
EP (1) EP1051620B1 (https=)
JP (1) JP2002529054A (https=)
AT (1) ATE329263T1 (https=)
AU (1) AU1458500A (https=)
CA (1) CA2317808A1 (https=)
DE (1) DE69931756T2 (https=)
IL (1) IL137121A0 (https=)
WO (1) WO2000026667A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918788D0 (en) 1999-08-10 1999-10-13 Leuven K U Res & Dev Antithrombotic effect of platelet glycoprotein 1b blocking monoclonal Fab fragments
DE10019967A1 (de) * 2000-04-20 2001-10-25 Fenning Biomed Gmbh Dr Antikörper gegen natives gp96, deren Herstellung und Verwendung
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
AU2003256299A1 (en) 2002-07-01 2004-01-19 Human Genome Sciences, Inc. Antibodies that specifically bind to reg iv
CA2491471A1 (en) * 2002-07-03 2004-01-15 The Trustees Of The University Of Pennsylvania Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof
WO2004044584A1 (en) * 2002-11-13 2004-05-27 Micromet Ag Method for identifying antigen specific b cells
MXPA06000252A (es) * 2003-06-30 2006-12-15 Bio Technology General Israel Anticuerpos y usos de los mismos.
EP1749536A1 (en) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Activated factor X stimulants as new antihemorrhagic agents for topical use
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
DK2186829T3 (en) 2008-11-14 2015-04-07 Canadian Blood Services Antibodies to GPIbalfa
WO2011053763A2 (en) * 2009-10-30 2011-05-05 Centocor Ortho Biotech Inc. Il-17a antagonists
EP4073123A4 (en) * 2019-12-10 2024-01-10 CCOA Therapeutics Inc. HUMANIZED ANTIBODIES IB ALPHA (GPIBALPHA) ANTIBODIES
JP7822313B2 (ja) * 2019-12-20 2026-03-02 メディミューン，エルエルシー グリピカン３を標的とするキメラ抗原受容体を用いて癌を治療する組成物及び方法
KR20230027267A (ko) * 2020-06-23 2023-02-27 카드몬 코포레이션, 엘엘씨 항-pd-1 항체 및 융합 단백질

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877155A (en) * 1995-03-17 1999-03-02 The Research Foundation Of State University Of New York Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
US5817748A (en) * 1995-03-17 1998-10-06 The Research Foundation Of State University Of New York Mimotopes of human Platelet glycoprotein Ib/IX

Also Published As

Publication number Publication date
JP2002529054A (ja) 2002-09-10
WO2000026667A1 (en) 2000-05-11
DE69931756D1 (de) 2006-07-20
WO2000026667A9 (en) 2001-04-12
EP1051620B1 (en) 2006-06-07
IL137121A0 (en) 2001-06-14
DE69931756T2 (de) 2007-05-24
AU1458500A (en) 2000-05-22
EP1051620A1 (en) 2000-11-15
EP1051620A4 (en) 2005-01-12
CA2317808A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
ATE329263T1 (de) Regionen variabler schwerer ketten und variabler leichter ketten von antikörpern für humanes blutplättchen-glykoprotein ib alpha
DE69429925D1 (de) METHODE ZUR BINDUNG VON MATERIAL AN DAS Beta-AMYLOID-PEPTID
SE9201331D0 (sv) Protein l och hybridproteiner daerav
HRP20090517T1 (hr) Protutijela na interleukin-10
DK0724456T3 (da) CD40-Antistoffer
DK0527839T3 (da) Rekombinant bibliotekscreeningsfremgangsmåder
CY1107708T1 (el) Ανθρωπινα μονοκλωνικα αντισωματα για υποδοχεα παραγοντα επιδερμικης αναπτυξης
BR0011849A (pt) Anticorpos enxertados lm609 melhorados
CR7343A (es) Anticuerpos para cd40
WO2003060080A3 (en) Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
MX9602971A (es) Anticuerpos humanizados contra la molecula vla-4 de adhesion de leucocitos.
DK0640135T3 (da) Immunoglobulinbindende proteiner, der er afledt af protein L, og anvendelser af disse
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
ATE290212T1 (de) Immunologische bestimmungen von prostata- spezifischem antigen
CY1112993T1 (el) Παραγοντες ειδικης δεσμευσης της αγγειοποιητινης-2 και της αγγειοποιητινης-1
DE69128543D1 (de) Monoklonale antikörper der maus
DK0720624T3 (da) Omdirigering af antistoffer
ATE332914T1 (de) Mimotope und antimimotope des menschlichen plättchen-glykoproteins ib/ix
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
DE69927668D1 (de) Massenfingerabdrucken und seiner verwendung zur identifizierung von protein-affinitätsliganden
DE60130804D1 (de) Antagonistischer antikörper gegen pro842
EP4501313A4 (en) Preparations containing a bispecific anti-Claudin 18.2/CD3 antibody, their preparation method and use
Hoag et al. Optimal conditions for isolating human placental alkaline phosphatase by immunosorption
SE9500148D0 (sv) Antibodies for use in cancer therapy and diagnosis
EP1293512A3 (en) DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties